Skip to content

Oruka Therapeutics, Inc. ORKA Investment Income Interest

Investment Income Interest at other companies

Oruka Therapeutics, Inc. logo
Oruka Therapeutics, Inc.ORKA
$4.61M+12.6%
Ondas, Inc.
 logo
Ondas, Inc. ONDS
$12.14M+5,938%
Accenture logo
AccentureACN
$75.07M-5.0%
SBA Communications logo
SBA CommunicationsSBAC
$5.21M-51.7%
Henry Schein logo
Henry ScheinHSIC
$7M+16.7%
Diodes logo
DiodesDIOD
$3.42M-19.7%

Other financials

Income statement

See full
Revenue-
Operating income-$36.4M-45.2%
Net income-$31.8M-51.5%
EPS (diluted)-$0.46+93.4%

Balance sheet

See full
Cash & equivalents$49.5M-40.7%
Total debt$1.8M+90.8%
Total equity$486.7M+33.4%
Total assets$504.5M+33.8%

Cash flow

See full
Operating cash flow-$23.6M-13.0%
CapEx$73.0K+462%
Free cash flow-$23.7M-13.3%

Valuation

See full
Market cap$4.36B+533%
Enterprise value$4.32B+690%

Returns & leverage

See full
Return on equity-27.3%-11.1pp
Debt / equity0.0×
Current ratio23.8×-6.3×

Where this comes from

Reported directly by Oruka Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:InvestmentIncomeInterest.

The official record: Oruka Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Oruka Therapeutics, Inc.'s investment income interest.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Oruka Therapeutics, Inc.'s investment income interest?
Oruka Therapeutics, Inc. (ORKA) reported investment income interest of $4.61M in Q1 2026.
How has Oruka Therapeutics, Inc.'s investment income interest changed year-over-year?
Oruka Therapeutics, Inc.'s investment income interest increased by 12.6% year-over-year, from $4.09M to $4.61M.
What does investment income interest mean?
Reflects the interest income earned on cash balances, marketable securities, and other short-term financial investments. This metric highlights the company's ability to generate returns on its idle capital reserves.